These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2729140)

  • 1. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
    Peters RW; Muller JE; Goldstein S; Byington R; Friedman LM
    Am J Cardiol; 1989 Jun; 63(20):1518-20. PubMed ID: 2729140
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality in the beta blocker heart attack trial: circumstances surrounding death.
    Peters RW; Byington R; Arensberg D; Friedman LM; Romhilt DW; Barker A; Laubach C; Wilner GW; Goldstein S
    J Chronic Dis; 1987; 40(1):75-82. PubMed ID: 3543049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
    Peters RW
    Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
    Hansteen V; Møinichen E; Lorentsen E; Andersen A; Strøm O; Søiland K; Dyrbekk D; Refsum AM; Tromsdal A; Knudsen K; Eika C; Bakken J; Smith P; Hoff PI
    Br Med J (Clin Res Ed); 1982 Jan; 284(6310):155-60. PubMed ID: 6799077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta Blocker Heart Attack Trial: design features.
    Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Norwegian propranolol trial in selected patients.
    Hansteen V
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):9S-12S. PubMed ID: 7052112
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blocking agents: current status in the prevention of sudden coronary death.
    Hjalmarson A
    Ann N Y Acad Sci; 1982; 382():305-23. PubMed ID: 6123286
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Beta-Blocker Heart Attack Trial in perspective.
    Goldstein S
    Cardiology; 1983; 70(5):255-62. PubMed ID: 6141847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inderal in the acute and post-myocardial infarct periods].
    Popov VG; Martynov IV; Alushkov MV; Voronin VA
    Ter Arkh; 1986; 58(6):53-8. PubMed ID: 3764715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of visit adherence in the national beta-blocker heart attack trial.
    Bell RL; Curb JD; Friedman LM; McIntyre KM; Payton-Ross C
    Control Clin Trials; 1985 Jun; 6(2):89-101. PubMed ID: 3891227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
    Baber NS; Evans DW; Howitt G; Thomas M; Wilson T; Lewis JA; Dawes PM; Handler K; Tuson R
    Br Heart J; 1980 Jul; 44(1):96-100. PubMed ID: 7000100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death.
    Shand DG; Pritchett EL; Hammill SC; Stargel WW; Wagner GS
    Ann N Y Acad Sci; 1982; 382():238-46. PubMed ID: 7044243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.